Global Nicotinamide Phosphoribosyltransferase Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Nicotinamide Phosphoribosyltransferase Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Nicotinamide Phosphoribosyltransferase report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Nicotinamide Phosphoribosyltransferase market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Parkinson's Disease and Acute Lung Injury are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Nicotinamide Phosphoribosyltransferase industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Nicotinamide Phosphoribosyltransferase key manufacturers include Genentech, Inc., Angelini Group, Calico LLC, FORMA Therapeutics, Inc., OncoTartis, Inc., Karyopharm Therapeutics, Inc. and Aurigene Discovery Technologies Limited, etc. Genentech, Inc., Angelini Group, Calico LLC are top 3 players and held % sales share in total in 2022.
Nicotinamide Phosphoribosyltransferase can be divided into Hormone, Lipids, Small Molecule Compounds and Others, etc. Hormone is the mainstream product in the market, accounting for % sales share globally in 2022.
Nicotinamide Phosphoribosyltransferase is widely used in various fields, such as Parkinson's Disease, Acute Lung Injury, Breast Cancer and Others, etc. Parkinson's Disease provides greatest supports to the Nicotinamide Phosphoribosyltransferase industry development. In 2022, global % sales of Nicotinamide Phosphoribosyltransferase went into Parkinson's Disease filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Nicotinamide Phosphoribosyltransferase market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Genentech, Inc.
Angelini Group
Calico LLC
FORMA Therapeutics, Inc.
OncoTartis, Inc.
Karyopharm Therapeutics, Inc.
Aurigene Discovery Technologies Limited
Segment by Type
Hormone
Lipids
Small Molecule Compounds
Others
Parkinson's Disease
Acute Lung Injury
Breast Cancer
Others
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Nicotinamide Phosphoribosyltransferase market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Nicotinamide Phosphoribosyltransferase, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Nicotinamide Phosphoribosyltransferase industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Nicotinamide Phosphoribosyltransferase in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Nicotinamide Phosphoribosyltransferase introduction, etc. Nicotinamide Phosphoribosyltransferase Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Nicotinamide Phosphoribosyltransferase market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
North America, Europe and Asia Pacific are the key regions for Nicotinamide Phosphoribosyltransferase industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Nicotinamide Phosphoribosyltransferase key manufacturers include Genentech, Inc., Angelini Group, Calico LLC, FORMA Therapeutics, Inc., OncoTartis, Inc., Karyopharm Therapeutics, Inc. and Aurigene Discovery Technologies Limited, etc. Genentech, Inc., Angelini Group, Calico LLC are top 3 players and held % sales share in total in 2022.
Nicotinamide Phosphoribosyltransferase can be divided into Hormone, Lipids, Small Molecule Compounds and Others, etc. Hormone is the mainstream product in the market, accounting for % sales share globally in 2022.
Nicotinamide Phosphoribosyltransferase is widely used in various fields, such as Parkinson's Disease, Acute Lung Injury, Breast Cancer and Others, etc. Parkinson's Disease provides greatest supports to the Nicotinamide Phosphoribosyltransferase industry development. In 2022, global % sales of Nicotinamide Phosphoribosyltransferase went into Parkinson's Disease filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Nicotinamide Phosphoribosyltransferase market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Genentech, Inc.
Angelini Group
Calico LLC
FORMA Therapeutics, Inc.
OncoTartis, Inc.
Karyopharm Therapeutics, Inc.
Aurigene Discovery Technologies Limited
Segment by Type
Hormone
Lipids
Small Molecule Compounds
Others
Segment by Application
Parkinson's Disease
Acute Lung Injury
Breast Cancer
Others
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Nicotinamide Phosphoribosyltransferase market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Nicotinamide Phosphoribosyltransferase, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Nicotinamide Phosphoribosyltransferase industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Nicotinamide Phosphoribosyltransferase in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Nicotinamide Phosphoribosyltransferase introduction, etc. Nicotinamide Phosphoribosyltransferase Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Nicotinamide Phosphoribosyltransferase market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.